317 related articles for article (PubMed ID: 22367997)
1. Nigral pathology and parkinsonian signs in elders without Parkinson disease.
Buchman AS; Shulman JM; Nag S; Leurgans SE; Arnold SE; Morris MC; Schneider JA; Bennett DA
Ann Neurol; 2012 Feb; 71(2):258-66. PubMed ID: 22367997
[TBL] [Abstract][Full Text] [Related]
2. Association of Parkinson disease risk loci with mild parkinsonian signs in older persons.
Shulman JM; Yu L; Buchman AS; Evans DA; Schneider JA; Bennett DA; De Jager PL
JAMA Neurol; 2014 Apr; 71(4):429-35. PubMed ID: 24514572
[TBL] [Abstract][Full Text] [Related]
3. Effects of Cerebrovascular and Lewy Body Pathology on Parkinsonian Signs in Community-Dwelling Older Adults.
Agrawal S; Leurgans SE; Nag S; Oveisgharan S; Barnes LL; Bennett DA; Buchman AS; Schneider JA
Neurology; 2023 Aug; 101(7):e754-e763. PubMed ID: 37438127
[TBL] [Abstract][Full Text] [Related]
4. Locus coeruleus neuron density and parkinsonism in older adults without Parkinson's disease.
Buchman AS; Nag S; Shulman JM; Lim AS; VanderHorst VG; Leurgans SE; Schneider JA; Bennett DA
Mov Disord; 2012 Nov; 27(13):1625-31. PubMed ID: 23038629
[TBL] [Abstract][Full Text] [Related]
5. Disentangling the relationship between lewy bodies and nigral neuronal loss in Parkinson's disease.
Parkkinen L; O'Sullivan SS; Collins C; Petrie A; Holton JL; Revesz T; Lees AJ
J Parkinsons Dis; 2011; 1(3):277-86. PubMed ID: 23939308
[TBL] [Abstract][Full Text] [Related]
6. Sex differences for clinical correlates of substantia nigra neuron loss in people with Lewy body pathology.
Bayram E; Coughlin DG; Rajmohan R; Litvan I
Biol Sex Differ; 2024 Jan; 15(1):8. PubMed ID: 38243325
[TBL] [Abstract][Full Text] [Related]
7. Neuropathology of sporadic Parkinson disease before the appearance of parkinsonism: preclinical Parkinson disease.
Ferrer I; Martinez A; Blanco R; Dalfó E; Carmona M
J Neural Transm (Vienna); 2011 May; 118(5):821-39. PubMed ID: 20862500
[TBL] [Abstract][Full Text] [Related]
8. Motor score of the Unified Parkinson Disease Rating Scale as a good predictor of Lewy body-associated neuronal loss in the substantia nigra.
Greffard S; Verny M; Bonnet AM; Beinis JY; Gallinari C; Meaume S; Piette F; Hauw JJ; Duyckaerts C
Arch Neurol; 2006 Apr; 63(4):584-8. PubMed ID: 16606773
[TBL] [Abstract][Full Text] [Related]
9. Lewy bodies and olfactory dysfunction in old age.
Wilson RS; Yu L; Schneider JA; Arnold SE; Buchman AS; Bennett DA
Chem Senses; 2011 May; 36(4):367-73. PubMed ID: 21257733
[TBL] [Abstract][Full Text] [Related]
10. Fragmentation of Golgi apparatus of nigral neurons with alpha-synuclein-positive inclusions in patients with Parkinson's disease.
Fujita Y; Ohama E; Takatama M; Al-Sarraj S; Okamoto K
Acta Neuropathol; 2006 Sep; 112(3):261-5. PubMed ID: 16855830
[TBL] [Abstract][Full Text] [Related]
11. A stable proportion of Lewy body bearing neurons in the substantia nigra suggests a model in which the Lewy body causes neuronal death.
Greffard S; Verny M; Bonnet AM; Seilhean D; Hauw JJ; Duyckaerts C
Neurobiol Aging; 2010 Jan; 31(1):99-103. PubMed ID: 18457903
[TBL] [Abstract][Full Text] [Related]
12. Stage-dependent nigral neuronal loss in incidental Lewy body and Parkinson's disease.
Dijkstra AA; Voorn P; Berendse HW; Groenewegen HJ; ; Rozemuller AJ; van de Berg WD
Mov Disord; 2014 Sep; 29(10):1244-51. PubMed ID: 24996051
[TBL] [Abstract][Full Text] [Related]
13. Ageing and Parkinson's disease: substantia nigra regional selectivity.
Fearnley JM; Lees AJ
Brain; 1991 Oct; 114 ( Pt 5)():2283-301. PubMed ID: 1933245
[TBL] [Abstract][Full Text] [Related]
14. Alpha-synuclein redistributes to neuromelanin lipid in the substantia nigra early in Parkinson's disease.
Halliday GM; Ophof A; Broe M; Jensen PH; Kettle E; Fedorow H; Cartwright MI; Griffiths FM; Shepherd CE; Double KL
Brain; 2005 Nov; 128(Pt 11):2654-64. PubMed ID: 16000336
[TBL] [Abstract][Full Text] [Related]
15. Nigral and cortical Lewy bodies and dystrophic nigral neurites in Parkinson's disease and cortical Lewy body disease contain alpha-synuclein immunoreactivity.
Irizarry MC; Growdon W; Gomez-Isla T; Newell K; George JM; Clayton DF; Hyman BT
J Neuropathol Exp Neurol; 1998 Apr; 57(4):334-7. PubMed ID: 9600226
[TBL] [Abstract][Full Text] [Related]
16. Centenary of Tretiakoff's thesis on the morphology of Parkinson's disease, evolved on the grounds of encephalitis lethargica pathology.
Holdorff B
J Hist Neurosci; 2019; 28(4):387-398. PubMed ID: 31226240
[TBL] [Abstract][Full Text] [Related]
17. Lewy pathology is not the first sign of degeneration in vulnerable neurons in Parkinson disease.
Milber JM; Noorigian JV; Morley JF; Petrovitch H; White L; Ross GW; Duda JE
Neurology; 2012 Dec; 79(24):2307-14. PubMed ID: 23152586
[TBL] [Abstract][Full Text] [Related]
18. TIGAR inclusion pathology is specific for Lewy body diseases.
López KLR; Simpson JE; Watson LC; Mortiboys H; Hautbergue GM; Bandmann O; Highley JR
Brain Res; 2019 Mar; 1706():218-223. PubMed ID: 30267647
[TBL] [Abstract][Full Text] [Related]
19. Apoptotic-like changes in Lewy-body-associated disorders and normal aging in substantia nigral neurons.
Tompkins MM; Basgall EJ; Zamrini E; Hill WD
Am J Pathol; 1997 Jan; 150(1):119-31. PubMed ID: 9006329
[TBL] [Abstract][Full Text] [Related]
20. Does levodopa accelerate the pathologic process in Parkinson disease brain?
Parkkinen L; O'Sullivan SS; Kuoppamäki M; Collins C; Kallis C; Holton JL; Williams DR; Revesz T; Lees AJ
Neurology; 2011 Oct; 77(15):1420-6. PubMed ID: 21917769
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
